Bank Julius Baer & Co
AZN icon

Bank Julius Baer & Co’s AstraZeneca AZN Stock Holding History

Bank Julius Baer & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367M Buy
1,949,007
+82,875
+4% +$15.6M 0.95% 26
2026
Q1 		$367M Buy
1,866,132
+962,693
+107% +$186M 1.11% 27
2025
Q4 		$166M Buy
903,439
+895,437
+11,190% +$157M 0.46% 54
2025
Q3 		$1.23M Sell
8,002
-1
-0% -$151 ﹤0.01% 357
2025
Q2 		$1.12M Buy
8,003
+5
+0.1% +$701 ﹤0.01% 326
2025
Q1 		$1.18M Buy
7,998
+754
+10% +$109K ﹤0.01% 307
2024
Q4 		$1.05M Buy
+7,244
New +$1.01M ﹤0.01% 313
2022
Q1 		– Sell
-20
Closed -$2K – 603
2021
Q4 		$2K Hold
20
– – ﹤0.01% 814
2021
Q3 		$2K Buy
20
+3
+18% +$349 ﹤0.01% 801
2021
Q2 		$2K Sell
17
-3
-15% -$329 ﹤0.01% 812
2021
Q1 		$2K Sell
20
-20
-50% -$2.01K ﹤0.01% 806
2020
Q4 		$4K Sell
40
-379
-90% -$40.1K ﹤0.01% 784
2020
Q3 		$46K Buy
+419
New +$46.6K ﹤0.01% 607

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank Julius Baer & Co's AZN Position: Q2 2026 in Review

Bank Julius Baer & Co increased its AstraZeneca (AZN) stake by 4.4% in Q2 2026, buying an estimated $15.6M and bringing the position to 1,949,007 shares worth $367M. The position accounts for 0.95% of the portfolio, ranked #26.

Bank Julius Baer & Co first reported a position in AZN in Q3 2020 and has held it in 13 quarters since. 1,501 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Bank Julius Baer & Co held 1,949,007 shares of AstraZeneca worth $367M as of Q2 2026.
  • Bank Julius Baer & Co bought 82,875 AstraZeneca shares in Q2 2026, an estimated $15.6M.
  • AstraZeneca made up 0.95% of Bank Julius Baer & Co's portfolio in Q2 2026, its #26 holding.
  • Bank Julius Baer & Co first reported a position in AstraZeneca in Q3 2020 and has held it in 13 quarters since.
  • 1,501 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.